CNS macrophages and peripheral myeloid cells in brain tumours

Acta Neuropathologica

Volumn 128, Issue 3, 2014, Pages 347-362

  Glass, Rainer ^a,d   Synowitz, Michael ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ANGIOGENESIS; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL ACTIVATION; CELL INVASION; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CYTOREDUCTIVE SURGERY; GLIOBLASTOMA; GLIOMA; HUMAN; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; MITOSIS RATE; MULTIMODALITY CANCER THERAPY; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TROPISM; TUMOR IMMUNITY; TUMOR INVASION; ANIMAL; BRAIN NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; HUMANS; MICROGLIA; MYELOID CELLS;

EID: 84906312886     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1274-2     Document Type: Review

References (172)

1. abd-el-Basset E, Fedoroff S (1995) Effect of bacterial wall lipopolysaccharide (LPS) on morphology, motility, and cytoskeletal organization of microglia in cultures. J Neurosci Res 41(2):222-237. doi:10.1002/jnr. 490410210
2. Adach A, Ellert-Miklaszewska A, Kaminska B (2009) Molecular characterization of STAT signaling in inflammation and tumorigenesis. Methods Mol Biol 512:265-278. doi:10.1007/978-1-60327-530-9-14
3. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM (2007) Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10(12):1538-1543. doi:10.1038/nn2014 (Pubitemid 350175883)
4. Badhiwala J, Decker WK, Berens ME, Bhardwaj RD (2013) Clinical trials in cellular immunotherapy for brain/CNS tumors. Expert Rev Neurother 13(4):405-424. doi:10.1586/ern.13.23
5. Badie B, Schartner J (2001) Role of microglia in glioma biology. Microsc Res Tech 54(2):106-113 (Pubitemid 32645875)
6. Badie B, Schartner J, Klaver J, Vorpahl J (1999) In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 44 (5):1077-1082 (discussion 1082-1073)
7. Badie B, Schartner JM (2000) Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46(4):957-961 (discussion 961-952)
8. Badie B, Schartner JM, Paul J, Bartley BA, Vorpahl J, Preston JK (2000) Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 93(4):634-639. doi:10.3171/jns.2000.93.4.0634 (Pubitemid 32799298)
9. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103(43):16021-16026. doi:10.1073/pnas.0607423103 (Pubitemid 44657585)
10. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM (2001) Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61(24):8730-8736 (Pubitemid 34013884)
11. Bettinger I, Thanos S, Paulus W (2002) Microglia promote glioma migration. Acta Neuropathol (Berl) 103(4):351-355 (Pubitemid 36097029)
12. Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, Den Dunnen WF, Boddeke HW, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP, Aldape K (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24(3):331-346. doi:10.1016/j.ccr.2013.08.001
13. Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, Sulman EP, Lang FF, Rao G, Copray S, Vaillant BD, Aldape KD (2011) The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev 25(24):2594-2609. doi:10.1101/gad.176800.111
14. Bielamowicz K, Khawja S, Ahmed N (2013) Adoptive cell therapies for glioblastoma. Front Oncol 3:275. doi:10.3389/fonc.2013.00275
15. Blay J, White TD, Hoskin DW (1997) The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57(13):2602-2605 (Pubitemid 27283766)
16. Boche D, Perry VH, Nicoll JA (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39(1):3-18. doi:10.1111/nan.12011
17. Bradley D, Rees J (2013) Updates in the management of high-grade glioma. J Neurol. doi:10.1007/s00415-013-7032-x
18. Brantley EC, Benveniste EN (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res MCR 6(5):675-684. doi:10.1158/1541-7786.MCR-07-2180
19. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, Network TR (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462-477. doi:10.1016/j.cell.2013.09.034
20. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL (2014) Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17(1):131-143. doi:10.1038/nn.3599
21. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463(7279):318-325. doi:10.1038/nature08712
22. Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M, Deschoemaeker S, Van Ginderachter JA, Tamagnone L, Mazzone M (2013) Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell 24(6):695-709. doi:10.1016/j.ccr.2013.11.007
23. Chen J, McKay RM, Parada LF (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149(1):36-47. doi:10.1016/j.cell. 2012.03.009
24. Ciechomska IA, Gabrusiewicz K, Szczepankiewicz AA, Kaminska B (2013) Endoplasmic reticulum stress triggers autophagy in malignant glioma cells undergoing cyclosporine a-induced cell death. Oncogene 32(12):1518-1529. doi:10.1038/onc.2012.174
25. Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB (2012) Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg 117(5):825-830. doi:10.3171/2012.7.JNS111260
26. Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, Segall JE (2012) Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med 18:519-527. doi:10.2119/molmed.2011.00217
27. Cooper LA, Gutman DA, Chisolm C, Appin C, Kong J, Rong Y, Kurc T, Van Meir EG, Saltz JH, Moreno CS, Brat DJ (2012) The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am J Pathol 180(5):2108-2119. doi:10.1016/j.ajpath.2012.01.040
28. Csoka B, Selmeczy Z, Koscso B, Nemeth ZH, Pacher P, Murray PJ, Kepka-Lenhart D, Morris SM Jr, Gause WC, Leibovich SJ, Hasko G (2012) Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J Off Publ Federation Am Soc Exp Biol 26(1):376-386. doi:10.1096/fj.11-190934
29. Cunningham CL, Martinez-Cerdeno V, Noctor SC (2013) Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci Off J Soc Neurosci 33(10):4216-4233. doi:10.1523/JNEUROSCI.3441-12.2013
30. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8(6):752-758. doi:10.1038/nn1472 (Pubitemid 43085841)
31. del Río-Hortega P (1921) Sobre la fagocitosis en los tumores y en otros procesos patológicos. In: Río-Hortega Pd (ed) Archivos de Cardiología y Hematología, vol 2, pp 161-220
32. Diserbo M, Agin A, Lamproglou I, Mauris J, Staali F, Multon E, Amourette C (2002) Blood-brain barrier permeability after gamma whole-body irradiation: an in vivo microdialysis study. Can J Physiol Pharmacol 80(7):670-678 (Pubitemid 35430404)
33. Dityatev A, Seidenbecher CI, Schachner M (2010) Compartmentalization from the outside: the extracellular matrix and functional microdomains in the brain. Trends Neurosci 33(11):503-512. doi:10.1016/j.tins.2010.08.003
34. Doucette T, Rao G, Rao A, Shen L, Aldape K, Wei J, Dziurzynski K, Gilbert M, Heimberger AB (2013) Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas. Cancer Immunol Res 1(112). doi:10.1158/2326-6066.CIR-13-0028
35. Ebert S, Gerber J, Bader S, Muhlhauser F, Brechtel K, Mitchell TJ, Nau R (2005) Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination. J Neuroimmunol 159(1-2):87-96. doi:10.1016/j.jneuroim.2004.10.005 (Pubitemid 40126180)
36. El Andaloussi A, Sonabend AM, Han Y, Lesniak MS (2006) Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia 54(6):526-535. doi:10.1002/glia.20401 (Pubitemid 44449333)
37. Ellert-Miklaszewska A, Dabrowski M, Lipko M, Sliwa M, Maleszewska M, Kaminska B (2013) Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 61(7):1178-1190. doi:10.1002/glia.22510
38. Engler JR, Robinson AE, Smirnov I, Hodgson JG, Berger MS, Gupta N, James CD, Molinaro A, Phillips JJ (2012) Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS ONE 7(8):e43339. doi:10.1371/journal.pone.0043339
39. Flugel A, Labeur MS, Grasbon-Frodl EM, Kreutzberg GW, Graeber MB (1999) Microglia only weakly present glioma antigen to cytotoxic T cells. Int J Dev Neurosci Off J Int Soc Dev Neurosci 17(5-6):547-556 (Pubitemid 29421841)
40. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD (1996) Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184(5):1737-1745 (Pubitemid 26404465)
41. Franke H, Verkhratsky A, Burnstock G, Illes P (2012) Pathophysiology of astroglial purinergic signalling. Purinergic Signal 8(3):629-657. doi:10.1007/s11302-012-9300-0
42. Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM (2012) Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338(6110):1080-1084. doi:10.1126/science.1226929
43. Gabrusiewicz K, Ellert-Miklaszewska A, Lipko M, Sielska M, Frankowska M, Kaminska B (2011) Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS ONE 6(8):e23902. doi:10.1371/journal.pone.0023902
44. Galarneau H, Villeneuve J, Gowing G, Julien JP, Vallieres L (2007) Increased glioma growth in mice depleted of macrophages. Cancer Res 67(18):8874-8881. doi:10.1158/0008-5472.CAN-07-0177 (Pubitemid 47437464)
45. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841-845. doi:10.1126/science.1194637
46. Goldmann T, Wieghofer P, Muller PF, Wolf Y, Varol D, Yona S, Brendecke SM, Kierdorf K, Staszewski O, Datta M, Luedde T, Heikenwalder M, Jung S, Prinz M (2013) A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci 16(11):1618-1626. doi:10.1038/nn.3531
47. Gomez Perdiguero E, Schulz C, Geissmann F (2013) Development and homeostasis of "resident" myeloid cells: the case of the microglia. Glia 61(1):112-120. doi:10.1002/glia.22393
48. Graeber MB, Scheithauer BW, Kreutzberg GW (2002) Microglia in brain tumors. Glia 40(2):252-259 (Pubitemid 35337382)
49. Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP, Nierkens S, Adema GJ (2008) TLR ligands in the local treatment of established intracerebral murine gliomas. J Immunol 181(10):6720-6729
50. Hanisch UK (2013) Proteins in microglial activation-inputs and outputs by subsets. Curr Protein Pept Sci 14(1):3-15
51. Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10(11):1387-1394. doi:10.1038/nn1997
52. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95(18):10896-10901 (Pubitemid 28413165)
53. Hart AD, Wyttenbach A, Perry VH, Teeling JL (2012) Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav Immun 26(5):754-765. doi:10.1016/j.bbi.2011.11.006
54. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25(1):33-39 (Pubitemid 38032805)
55. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. New Engl J Med 352(10):997-1003. doi:10.1056/NEJMoa043331 (Pubitemid 40349502)
56. Heimberger AB, Sampson JH (2011) Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma? Neuro Oncol 13(1):3-13. doi:10.1093/neuonc/noq169
57. Held-Feindt J, Hattermann K, Muerkoster SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM, Mentlein R (2010) CX3CR1 promotes recruitment of human gliomainfiltrating microglia/macrophages (GIMs). Exp Cell Res 316(9):1553-1566. doi:10.1016/j.yexcr.2010.02.018
58. Herculano-Houzel S (2009) The human brain in numbers: a linearly scaled-up primate brain. Front Hum Neurosci 3:31. doi:10.3389/neuro.09.031.2009
59. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, El Khoury J (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16(12):1896-1905. doi:10.1038/nn.3554
60. Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, Priebe W, Heimberger AB (2007) A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67(20):9630-9636. doi:10.1158/0008-5472.CAN-07-1243 (Pubitemid 47621208)
61. Hussain SF, Yang D, Suki D, Aldape K, Grimm E, Heimberger AB (2006) The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol 8(3):261-279. doi:10.1215/15228517-2006-008 (Pubitemid 46542651)
62. Ishihara H, Kubota H, Lindberg RL, Leppert D, Gloor SM, Errede M, Virgintino D, Fontana A, Yonekawa Y, Frei K (2008) Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins. J Neuropathol Exp Neurol 67(5):435-448. doi:10.1097/NEN.0b013e31816fd622 (Pubitemid 351653535)
63. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP (2005) TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175(7):4320-4330 (Pubitemid 41361966)
64. Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA (2012) Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol 14(2):119-131. doi:10.1093/neuonc/nor194
65. Janicki CN, Jenkinson SR, Williams NA, Morgan DJ (2008) Loss of CTL function among high-avidity tumor-specific CD8 + T cells following tumor infiltration. Cancer Res 68(8):2993-3000. doi:10.1158/0008-5472.CAN-07-5008 (Pubitemid 351556300)
66. Jansen T, Tyler B, Mankowski JL, Recinos VR, Pradilla G, Legnani F, Laterra J, Olivi A (2010) FasL gene knock-down therapy enhances the antiglioma immune response. Neuro Oncol 12(5):482-489. doi:10.1093/neuonc/nop052
67. Jantaratnotai N, Choi HB, McLarnon JG (2009) ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer 9:442. doi:10.1186/1471-2407-9-442
68. Joseph J, Knobler RL, D'Imperio C, Lublin FD (1988) Downregulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta: effects of dosage treatment schedule. J Neuroimmunol 20(1):39-44
69. Kaminska B, Kocyk M, Kijewska M (2013) TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol 986:171-187. doi:10.1007/978-94-007-4719- 7-9
70. Kaneko YS, Ota A, Nakashima A, Mori K, Nagatsu I, Nagatsu T (2012) Regulation of oxidative stress in long-lived lipopolysaccharide-activated microglia. Clin Exp Pharmacol Physiol 39(7):599-607. doi:10.1111/j.1440-1681. 2012.05716.x
71. Kees T, Lohr J, Noack J, Mora R, Gdynia G, Todt G, Ernst A, Radlwimmer B, Falk CS, Herold-Mende C, Regnier-Vigouroux A (2012) Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro Oncol 14(1):64-78. doi:10.1093/neuonc/nor182
72. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2):461-553. doi:10.1152/physrev.00011.2010
73. Kettenmann H, Kirchhoff F, Verkhratsky A (2013) Microglia: new roles for the synaptic stripper. Neuron 77(1):10-18. doi:10.1016/j.neuron.2012.12.023
74. Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Holscher C, Muller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M (2013) Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 16(3):273-280. doi:10.1038/nn.3318
75. Kim J, Hajjar KA (2002) Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci J Virtual Libr 7:d341-d348
76. Kleihues PB, Burger PC, Scheithauer BW (1996) Histological typing of the tumours of the central nervous system. International histological classification of tumours, 2nd edn. Springer, Stuttgart
77. Kloss CU, Bohatschek M, Kreutzberg GW, Raivich G (2001) Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol 168(1):32-46. doi:10.1006/exnr.2000.7575 (Pubitemid 32195256)
78. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A, Ishiguro N, Kadomatsu K (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 4:e525. doi:10.1038/cddis.2013.54
79. Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216(1):15-24. doi:10.1002/path.2370
80. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mule J, Kerr WG, Jove R, Pardoll D, Yu H (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11(12):1314-1321. doi:10.1038/nm1325 (Pubitemid 41752912)
81. Ku MC, Wolf SA, Respondek D, Matyash V, Pohlmann A, Waiczies S, Waiczies H, Niendorf T, Synowitz M, Glass R, Kettenmann H (2013) GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathol 125(4):609-620. doi:10.1007/s00401-013-1079-8
82. Kurpad SN, Wikstrand CJ, Bigner DD (1994) Immunobiology of malignant astrocytomas. Semin Oncol 21(2):149-161 (Pubitemid 24125955)
83. Lakka SS, Gondi CS, Rao JS (2005) Proteases and glioma angiogenesis. Brain Pathol 15(4):327-341 (Pubitemid 41677432)
84. Lawson LJ, Perry VH, Dri P, Gordon S (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39(1):151-170
85. Li B, Senbabaoglu Y, Peng W, Yang ML, Xu J, Li JZ (2012) Genomic estimates of aneuploid content in glioblastoma multiforme and improved classification. Clinical Cancer Res Off J Am Assoc Cancer Res 18(20):5595-5605. doi:10.1158/1078-0432.CCR-12-1427
86. Linden J (2006) Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway". Am J Physiol Cell Physiol 291(3):C405-C406. doi:10.1152/ajpcell.00242.2006
87. Liu C, Luo D, Streit WJ, Harrison JK (2008) CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J Neuroimmunol 198(1-2):98-105. doi:10.1016/j.jneuroim.2008.04.016
88. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109. doi:10.1007/s00401-007- 0243-4 (Pubitemid 47103521)
89. Luongo L, Guida F, Imperatore R, Napolitano F, Gatta L, Cristino L, Giordano C, Siniscalco D, Di Marzo V, Bellini G, Petrelli R, Cappellacci L, Usiello A, de Novellis V, Rossi F, Maione S (2014) The A1 adenosine receptor as a new player in microglia physiology. Glia 62(1):122-132. doi:10.1002/glia.22592
90. Machein MR, Renninger S, de Lima-Hahn E, Plate KH (2003) Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 13(4):582-597 (Pubitemid 37420701)
91. Mark R. Gilbert JD, Minhee Won, Deborah T. Blumenthal, Michael A. Vogelbaum, Kenneth D. Aldape, Howard Colman, Arnab Chakravarti, Robert Jeraj, Terri S. Armstrong, Jeffrey Scott Wefel, Paul D. Brown, Kurt A. Jaeckle, David Schiff, James Norman Atkins, David Brachman, Maria Werner-Wasik, Ritsuko Komaki, Erik P. Sulman, Minesh P. Mehta; University of Texas MD Anderson Cancer Center Department of Neuro-Oncology, Houston, TX; Radiation Therapy Oncology Group, Philadelphia, PA; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Cleveland Clinic Foundation, Cleveland, OH; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT; Arthur G. James Cancer Center, The Ohio State University, Columbus, OH; Department of Medical Physics, University of Wisconsin, Madison, WI; University of Texas Health Science Center School of Nursing, Houston, TX; Mayo Clinic, Jacksonville, FL; University of Virginia Medical Center, Charlottesville, VA; National Surgical Adjuvant Breast and Bowel Project and SCCC-CCOP, Goldboro, NC; Arizona Oncology Services Foundation, Phoenix, AZ; Thomas Jefferson University Hospital, Philadelphia, PA; University of Maryland, Baltimore, MD (2013) RTOG 0825: Phase III double-blind, placebo-controlled trial evaluating bevacizumab in patiens with newly diagnosed glioblastoma. Paper presented at the ASCO Annual Meeting
92. Markovic DS, Glass R, Synowitz M, Rooijen N, Kettenmann H (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64(9):754-762 (Pubitemid 41285807)
93. Markovic DS, Vinnakota K, Chirasani S, Synowitz M, Raguet H, Stock K, Sliwa M, Lehmann S, Kalin R, van Rooijen N, Holmbeck K, Heppner FL, Kiwit J, Matyash V, Lehnardt S, Kaminska B, Glass R, Kettenmann H (2009) Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci USA 106(30):12530-12535. doi:10.1073/pnas.0804273106
94. Markovic DS, Vinnakota K, van Rooijen N, Kiwit J, Synowitz M, Glass R, Kettenmann H (2011) Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun 25(4):624-628. doi:10.1016/j.bbi.2011.01.015
95. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Bruck W, Priller J, Prinz M (2007) Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 10(12):1544-1553. doi:10.1038/nn2015 (Pubitemid 350175884)
96. Morioka T, Baba T, Black KL, Streit WJ (1992) Response of microglial cells to experimental rat glioma. Glia 6(1):75-79. doi:10.1002/glia.440060110
97. Mosieniak G, Figiel I, Kaminska B (1997) Cyclosporin A, an immunosuppressive drug, induces programmed cell death in rat C6 glioma cells by a mechanism that involves the AP-1 transcription factor. J Neurochem 68(3):1142-1149 (Pubitemid 27086219)
98. Naganuma H, Sasaki A, Satoh E, Nagasaka M, Nakano S, Isoe S, Nukui H (1998) Down-regulation of transforming growth factor-beta and interleukin-10 secretion from malignant glioma cells by cytokines and anticancer drugs. J Neurooncol 39(3):227-236 (Pubitemid 28482558)
99. Nakano Y, Kuroda E, Kito T, Uematsu S, Akira S, Yokota A, Nishizawa S, Yamashita U (2008) Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase-1 expression in murine microglia by glioma-derived soluble factors. Laboratory investigation. J Neurosurg 108(2):311-319. doi:10.3171/JNS/2008/108/2/0311 (Pubitemid 351213296)
100. Nieto MA (2011) The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27:347-376. doi:10.1146/annurev-cellbio-092910-154036
101. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726):1314-1318. doi:10.1126/science.1110647 (Pubitemid 40746128)
102. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M (1999) Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res Off J Am Assoc Cancer Res 5(5):1107-1113 (Pubitemid 29233226)
103. Norden AD, Drappatz J, Wen PY (2009) Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 5(11):610-620. doi:10.1038/nrneurol.2009.159
104. Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170(5):1445-1453 (Pubitemid 47339290)
105. Ohnishi T, Matsumura H, Izumoto S, Hiraga S, Hayakawa T (1998) A novel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 58(14):2935-2940 (Pubitemid 28335065)
106. Okada M, Saio M, Kito Y, Ohe N, Yano H, Yoshimura S, Iwama T, Takami T (2009) Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int J Oncol 34(6):1621-1627
107. Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA J Am Med Assoc 310(17):1842-1850. doi:10.1001/jama.2013. 280319
108. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15(Suppl 2):ii1-ii56. doi:10.1093/neuonc/not151
109. Pagano M, Reboud-Ravaux M (2011) Cryptic activities of fibronectin fragments, particularly cryptic proteases. Front Biosci (Landmark Ed) 16:698-706
110. Paolicelli RC, Gross CT (2011) Microglia in development: linking brain wiring to brain environment. Neuron Glia Biol 7(1):77-83. doi:10.1017/ S1740925X12000105
111. Parney IF, Waldron JS, Parsa AT (2009) Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg 110(3):572-582. doi:10.3171/2008.7.JNS08475
112. Penfield W (1925) Microglia and the process of phagocytosis in gliomas. Am J Pathol 1(1):77-90
113. Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I, Garcia-Dorado D, Poca MA, Sahuquillo J, Baselga J, Seoane J (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15(4):315-327. doi:10.1016/j.ccr.2009.02.011
114. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173 (Pubitemid 43357943)
115. Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF (2013) Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clin Cancer Res Off J Am Assoc Cancer Res 19(16):4392-4403. doi:10.1158/1078-0432.CCR-12-1557
116. Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV, de Groot JF (2012) Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol 14(11):1379-1392. doi:10.1093/neuonc/nos158
117. Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54(3):388-392 (Pubitemid 37072043)
118. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernandez-Klett F, Prass K, Bechmann I, de Boer BA, Frotscher M, Kreutzberg GW, Persons DA, Dirnagl U (2001) Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 7(12):1356-1361. doi:10.1038/nm1201-1356 (Pubitemid 34007942)
119. Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V, Setty M, Leslie CS, Oei Y, Pedraza A, Zhang J, Brennan CW, Sutton JC, Holland EC, Daniel D, Joyce JA (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19(10):1264-1272. doi:10.1038/nm.3337
120. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39-51. doi:10.1016/j.cell.2010.03.014
121. Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y, Muldowney MT, Reynolds SL, Yanagisawa LL, Fox TH 3rd, Park K, Harrington LE, Raman C, Benveniste EN (2012) Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc Natl Acad Sci USA 109(13):5004-5009. doi:10.1073/pnas.1117218109
122. Raivich G (2005) Like cops on the beat: the active role of resting microglia. Trends Neurosci 28(11):571-573. doi:10.1016/j.tins.2005.09.001
123. Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ (2007) Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol Biol Cell 18(1):14-23. doi:10.1091/mbc.E06-07-0596 (Pubitemid 46066706)
124. Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12(9):623-635. doi:10.1038/nri3265
125. Ribes S, Adam N, Schutze S, Regen T, Redlich S, Janova H, Borisch A, Hanisch UK, Nau R (2012) The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells. J Neuroimmunol 252(1-2):16-23. doi:10.1016/j.jneuroim.2012.07. 012
126. Roggendorf W, Strupp S, Paulus W (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92(3):288-293 (Pubitemid 26278960)
127. Rolle CE, Sengupta S, Lesniak MS (2012) Mechanisms of immune evasion by gliomas. Adv Exp Med Biol 746:53-76. doi:10.1007/978-1-4614-3146-6-5
128. Rutka JT, Apodaca G, Stern R, Rosenblum M (1988) The extracellular matrix
129. Sahm F, Oezen I, Opitz CA, Radlwimmer B, von Deimling A, Ahrendt T, Adams S, Bode HB, Guillemin GJ, Wick W, Platten M (2013) The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res 73(11):3225-3234. doi:10.1158/0008-5472.CAN-12-3831
130. Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11(11):775-787. doi:10.1038/nri3086
131. Sanai N, Berger MS (2012) Recent surgical management of gliomas. Adv Exp Med Biol 746:12-25. doi:10.1007/978-1-4614-3146-6-2
132. Sarkar S, Doring A, Zemp FJ, Silva C, Lun X, Wang X, Kelly J, Hader W, Hamilton M, Mercier P, Dunn JF, Kinniburgh D, van Rooijen N, Robbins S, Forsyth P, Cairncross G, Weiss S, Yong VW (2014) Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nat Neurosci 17(1):46-55. doi:10.1038/nn.3597
133. Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkarni N, Badie B (2005) Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51(4):279-285. doi:10.1002/glia.20201 (Pubitemid 41532103)
134. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336(6077):86-90. doi:10.1126/science.1219179
135. Schwaighofer H, Kernan NA, O'Reilly RJ, Brankova J, Nachbaur D, Herold M, Eibl B, Niederwieser D (1996) Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution. Transplantation 62(7):947-953 (Pubitemid 26360356)
136. Seiki M (2003) Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 194(1):1-11. S0304383502006997 [pii]
137. Sengupta S, Marrinan J, Frishman C, Sampath P (2012) Impact of temozolomide on immune response during malignant glioma chemotherapy. Clin Dev Immunol 2012:831090. doi:10.1155/2012/831090
138. Shechter R, Schwartz M (2013) Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J Pathol 229(2):332-346. doi:10.1002/path.4106
139. Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T (1988) Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. J Neurosurg 68(2):259-265. doi:10.3171/jns.1988.68.2.0259 (Pubitemid 18057734)
140. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42(6):717-727. doi:10.1016/j.ejca.2006.01.003
141. Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B (2013) Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J Pathol 230(3):310-321. doi:10.1002/path.4192
142. Sliwa M, Markovic D, Gabrusiewicz K, Synowitz M, Glass R, Zawadzka M, Wesolowska A, Kettenmann H, Kaminska B (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain J Neurol 130(Pt 2):476-489 (Pubitemid 46181101)
143. Sonabend AM, Rolle CE, Lesniak MS (2008) The role of regulatory T cells in malignant glioma. Anticancer Res 28(2B):1143-1150 (Pubitemid 351578852)
144. Streit WJ (1994) Cellular immune response in brain tumors. Neuropathol Appl Neurobiol 20(2):205-206
145. Suzumura A, Sawada M, Yamamoto H, Marunouchi T (1993) Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151(4):2150-2158 (Pubitemid 23235688)
146. Synowitz M, Glass R, Farber K, Markovic D, Kronenberg G, Herrmann K, Schnermann J, Nolte C, van Rooijen N, Kiwit J, Kettenmann H (2006) A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Res 66(17):8550-8557 (Pubitemid 44449168)
147. Tabatabai G, Bahr O, Mohle R, Eyupoglu IY, Boehmler AM, Wischhusen J, Rieger J, Blumcke I, Weller M, Wick W (2005) Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain J Neurol 128(Pt 9):2200-2211. doi:10.1093/brain/awh563 (Pubitemid 41253286)
148. Tammela T, Zarkada G, Nurmi H, Jakobsson L, Heinolainen K, Tvorogov D, Zheng W, Franco CA, Murtomaki A, Aranda E, Miura N, Yla-Herttuala S, Fruttiger M, Makinen T, Eichmann A, Pollard JW, Gerhardt H, Alitalo K (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13(10):1202-1213. doi:10.1038/ncb2331
149. Tatter SB (2002) Recurrent malignant glioma in adults. Curr Treat Options Oncol 3(6):509-524
150. van Hinsbergh VW, Koolwijk P (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78(2):203-212. doi:10.1093/cvr/cvm102
151. Veeravagu A, Jiang B, Ludwig C, Chang SD, Black KL, Patil CG (2013) Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Systematic Rev 4:CD009319. doi:10.1002/14651858.CD009319.pub2
152. Vega EA, Graner MW, Sampson JH (2008) Combating immunosuppression in glioma. Future Oncol 4(3):433-442. doi:10.2217/14796694.4.3.433 (Pubitemid 351984094)
153. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110. doi:10.1016/j.ccr.2009.12.020
154. Vince GH, Wagner S, Pietsch T, Klein R, Goldbrunner RH, Roosen K, Tonn JC (1999) Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int J Dev Neurosci Off J Int Soc Dev Neurosci 17(5-6):437-445 (Pubitemid 29421831)
155. Vinnakota K, Hu F, Ku MC, Georgieva PB, Szulzewsky F, Pohlmann A, Waiczies S, Waiczies H, Niendorf T, Lehnardt S, Hanisch UK, Synowitz M, Markovic D, Wolf SA, Glass R, Kettenmann H (2013) Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro Oncol. doi:10.1093/neuonc/not115
156. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827-839. doi:10.1161/01.RES.0000070112.80711.3D (Pubitemid 36542523)
157. Vukovic J, Colditz MJ, Blackmore DG, Ruitenberg MJ, Bartlett PF (2012) Microglia modulate hippocampal neural precursor activity in response to exercise and aging. J Neurosci Off J Soc Neurosci 32(19):6435-6443. doi:10.1523/ JNEUROSCI.5925-11.2012
158. Wagner S, Czub S, Greif M, Vince GH, Suss N, Kerkau S, Rieckmann P, Roggendorf W, Roosen K, Tonn JC (1999) Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int J Cancer J 82(1):12-16 (Pubitemid 29266099)
159. Wainwright DA, Dey M, Chang A, Lesniak MS (2013) Targeting tregs in malignant brain cancer: overcoming IDO. Front Immunol 4:116. doi:10.3389/fimmu.2013.00116
160. Walker C, Baborie A, Crooks D, Wilkins S, Jenkinson MD (2011) Biology, genetics and imaging of glial cell tumours. Br J Radiol 84 Spec No 2:S90-S106. doi:10.1259/bjr/23430927
161. Wang SC, Hong JH, Hsueh C, Chiang CS (2012) Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Investig J Tech Methods Pathol 92(1):151-162. doi:10.1038/labinvest. 2011.128
162. Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81(3):447-455 (Pubitemid 41359299)
163. Wei J, Gabrusiewicz K, Heimberger A (2013) The controversial role of microglia in malignant gliomas. Clin Dev Immunol 2013:285246. doi:10.1155/2013/285246
164. Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger AB (2013) miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 73(13):3913-3926. doi:10.1158/0008-5472. CAN-12-4318
165. Wesolowska A, Kwiatkowska A, Slomnicki L, Dembinski M, Master A, Sliwa M, Franciszkiewicz K, Chouaib S, Kaminska B (2008) Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 27(7):918-930. doi:10.1038/sj.onc.1210683 (Pubitemid 351225378)
166. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A (2003) Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2(7):395-403 (Pubitemid 36793931)
167. Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12(3):341-349
168. Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL, Jiang XF, Yang L, Zhang P, Qian C, Cui YH, Zhang X, Bian XW (2012) Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 189(1):444-453. doi:10.4049/jimmunol.1103248
169. Yi L, Xiao H, Xu M, Ye X, Hu J, Li F, Li M, Luo C, Yu S, Bian X, Feng H (2011) Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J Neuroimmunol 232(1-2):75-82. doi:10.1016/j.jneuroim.2010. 10.011
170. Yuan H, Gaber MW, McColgan T, Naimark MD, Kiani MF, Merchant TE (2003) Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies. Brain Res 969(1-2):59-69 (Pubitemid 36369613)
171. Zhang L, Alizadeh D, Van Handel M, Kortylewski M, Yu H, Badie B (2009) Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. Glia 57(13):1458-1467. doi:10.1002/glia.20863
172. Zhang L, Handel MV, Schartner JM, Hagar A, Allen G, Curet M, Badie B (2007) Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia. J Neuroimmunol 184(1-2):188-197. doi:10.1016/j.jneuroim.2006.12.006 (Pubitemid 46366001)